Background: The selective proliferation of transplanted hepatocytes by providing a
Introduction
Hepatocyte transplantation (HT) has been performed in both animal experiments and in patients with hepatic inherited disorders (1) (2) (3) (4) . Because the number of hepatocytes transplanted safely at one time is limited due to the occurrence of portal hypertension, transplanted hepatocytes need to proliferate in the host liver to completely correct the underlying disorder (5, 6) . Selective proliferation of transplanted hepatocytes by providing a growth stimulus by partial hepatectomy of the host liver, combined with hepatic irradiation (HIR) of the whole liver that can suppress proliferation of host hepatocytes, and consequently, almost the whole liver would be constructed with donor hepatocytes (7) . Moreover, jaundiced Gunn rats of Crigler-Najjar syndrome type I model, which lack hepatic uridinediphosphoglucuronate glucuronosyltransferase (UGT1A1) activity, had UGT1A1 protein and enzymatic activity in the liver, and normalization of serum bilirubin levels (8) . Although these results are very attractive, hepatectomy is too invasive to be carried out in patients. Instead of hepatectomy, Fas-mediated apoptosis of host hepatocytes (9) or administration of a recombinant adenovirus vector expressing hepatocyte growth factor (HGF) (10, 11) has been successful in inducing massive repopulation of transplanted hepatocytes. However, these strategies appear difficult to implement clinically because of potential toxicity. Miyazaki, Yamanouchi, et al. 6 Irradiation-induced apoptosis of hepatocytes and sinusoidal endothelial cells within 24 hours after HIR improved by one week (12) .
Chronically, radiation-induced liver disease (RILD), characterized by histopathologic features of veno-occlusive disease, could occur within several months after hepatic radiation therapy, and the patient, with irradiation of an extended liver volume, would show fatigue, weight gain, hepatomegaly, and ascites (13 
Materials and Methods

Animals
Male wild-type F344 rats and dipeptidyl peptidase (DPP) IV deficient (DPPI−)
F344 rats weighing 200-250 g were obtained commercially (Japan SLC, Inc., Hamamatsu, Japan and Charles River Laboratories Japan, Inc., Yokohama, Japan, respectively). Both jaundiced Gunn/Slc-j/j and Gunn/Slc-j/ − (non-jaundiced) were purchased from Japan SLC, Inc. The animals were housed in a temperature-controlled environment with a 12-hr light/dark cycle and had free access to standard rat chow and water. All experiments were performed according to the Guidelines for Animal Experimentation at Nagasaki University.
I) Experiment to assess the efficacy of preparative partial HIR+PVBL Miyazaki, Yamanouchi, et al.
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Isolation of hepatocytes
The cells were isolated with a modified collagenase perfusion method using male wild-type F344 rats or non-jaundiced Gunn/Slc-j/−rats, as originally described by Berry and Friend (19) . After liver dissociation, the cells were filtered through a 70-μm Cell Strainer (Becton, Dickinson and Company, NJ, USA) and washed twice at 50×g for 2 min each. Cell viability was determined by trypan blue dye exclusion. Hepatocytes above 80% viability were used for transplantation.
Partial hepatic irradiation and portal vein branch ligation
Anesthesia was induced by ether inhalation and was maintained by the intraperitoneal injection of pentobarbital sodium with recipient animals (DPPIV− F344 or jaundiced Gunn/Slc-j/j rats) and a transverse abdominal incision was made. For partial hepatic irradiation (HIR) to only the left lateral lobe at 50 Gy, lead shields (2 mm thick) were placed to protect the other hepatic lobes and other abdominal organs. A X-ray irradiation device (ISOVOLT TITAN 320; GE Inspection Technologies Ltd., Tokyo, Japan) was used (320 kVP, 5 mA, and 0.5 mm Cu + 0.5 mm Al filtration at dose rate 0.87 Gy/min). Immediately after partial HIR, the portal vein supplying 20% of the liver was ligated to induce growth stimulus ( Fig. 1) . Thereafter, the abdomen was closed.
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Hepatocyte transplantation
One to 3 days after the preparation, fresh hepatocytes were injected intrasplenically. Hepatocytes at 1×10 7 from wild-type F344 rats or non-jaundiced Gunn/Slc-j/-rats were injected in either the anesthetized recipient DPPIV−F344 rats or the jaundiced Gunn rats, respectively.
Experimental design DPPIV rat experiment
Six rats underwent HT after partial HIR+PVBL. Two rats were killed at 4 and 16 weeks after HT, respectively, and samples were collected for DPPIV histochemistry, PAS stain, and immunohistochemistry.
Gunn rat experiment
The rats were divided into three groups according to preparations (six for the non-HT group; only HIR+PVBL without HT, six for the PVBL group; HT following only PVBL, and eight for HIR+PVBL group; HT following HIR+PVBL). Serum was collected from all the rats weekly until 24 weeks after HT to measure the serum bilirubin levels.
Identification of transplanted cells by DPPIV histochemistry
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DPPIV enzyme activity was detected as previously described (12 
Serum bilirubin concentrations
The serum bilirubin concentrations were determined by enzymatic methods at SRL, Inc. (Tokyo, Japan).
Detection of glycogen storage by PAS stain
Tissue glycogen was determined by incubation in 1% aqueous periodic acid for 5 min and Schiff's reagent for another 15 min with cryostat sections fixed with cold methanol (20) .
Structural and functional investigation by immunohistochemistry
To investigate whether repopulated donor hepatocytes had liver-specific structure Miyazaki, Yamanouchi, et al.
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and function, cryostat sections fixed with cold acetone were stained using the mouse monoclonal anti-connexin 32 antibody (Abcam plc., Cambridge, UK) and the rabbit polyclonal anti-PCK-1 antibody (Abcam plc). The antibody binding was then visualized using an EnVision/HRP (DAKO Japan corp., Tokyo, Japan).
Proliferation cell nuclear antigen staining Proliferation cell nuclear antigen (PCNA) staining was performed to detect DNA synthesis as a marker of hepatocellular mitosis in response to the preparative treatments. Other four DPPIV−F344 rats underwent HIR+PVBL, and 2 rats were killed on days 1 and 2 after the procedures, respectively.
Immunohistochemical staining was performed using the mouse monoclonal anti-PCNA antibody (DAKO Japan corp.) and an EnVision/HRP with formalin-fixed paraffin-embedded sections.
Serum hepatocyte growth factor levels after HIR+PVBL
To investigate the changes in serum hepatocyte growth factor (HGF) levels, we performed HIR+PVBL without HT in the additional five DPPIV−F344 rats Serum specimens were collected 1, 3, 7, 14, 21, and 28 days after surgery. The serum levels of HGF were measured using a Quantikine ELISA Mouse/Rat HGF Immunoassay kit (R&D Systems, Inc., MN, USA). The pellet obtained by collagenase perfusion and centrifugation at 50×g was additionally centrifuged through 45% Percoll at 50×g for 24 min. The pellet thus obtained was further centrifuged at 50×g for 1 min, and the pellet and supernatant were used as a fraction of PHs and SHs, respectively.
Isolation of ADMSCs
ADMSCs were isolated from rat peritoneal adipose tissue specimens obtained from wild-type F344 rats as reported previously with some modifications (21).
The tissue was rinsed with cold PBS (Life Technologies Japan Co., Tokyo, Japan.) and minced into small fragments with a blade. The fragments were digested 
Experimental design
Following HIR+PVBL, SHs or PHs (2×10 6 ), or ADMSCs of P2 to P4 (5×10 6 ) were transplanted to four DPPIV−F344 rats, respectively. They were then sacrificed 8 weeks after HT for DPPIV histochemistry.
Statistical analysis
The results are expressed as the mean ± standard deviation (SD).
Mann-Whitney's U test was used for the comparison of 2 groups. Data were analyzed using the analysis of variance (ANOVA) for multiple comparisons. A p-value of less than 0.05 was considered to be statistically significant.
Results
Repopulation of transplanted hepatocytes in the irradiated lobes
14 After HT following preparative partial HIR+PVBL, transplanted hepatocytes grew and, subsequently, showed massive repopulation only in the irradiated lobes after 16 weeks, but did not display a similar behavior in the non-irradiated lobes ( Fig. 2A) . In addition, immunohistochemical and PAS stains demonstrated expression of connexin 32, PCK-1, and glycogen storage in the repopulated hepatocytes, similar to the native liver ( Figure. 2B, C, and D).
Changes in the serum bilirubin concentrations
Although the rats in the PVBL group showed significant, but transient decrease in serum bilirubin concentrations at 4 weeks after transplantation, the level recovered to preoperative value at 7 weeks and remained constant during the observation period (24 weeks). In the HIR+PVBL group rats, serum bilirubin levels were reduced by 59.1% at 4 weeks after transplantation and kept this level for the remaining period of the observation (Fig. 3) . The animals in the non-HT group did not show any significant changes in their bilirubin levels.
Regenerative response after partial HIR+PVBL DNA synthesis in proliferative hepatocytes was examined using PCNA staining.
While in the non-irradiated liver lobe, many cells were PCNA-positive at 2 days after HIR+PVBL; in contrast, very few hepatocytes were PCNA-positive in the irradiated lobe (Fig. 4) . To investigate the relevance of serum HGF with repopulation of transplanted hepatocytes, we measured its concentrations over time after HIR+PVBL by ELISA. Unexpectedly, the serum HGF levels did not increase for at least 4 weeks (Fig. 5 ).
Engraftment and repopulation of SHs and ADMSCs
After 8 weeks of transplantation, a massive hepatic repopulation was acquired in the irradiated lobes with SHs, even with a small number of cells being transplanted initially (Fig. 6A) . The transplanted SHs proliferated more rapidly in the irradiated recipient's liver compared with the PHs (38.5% vs. 7.2%, p<0.038) (Fig. 6E ). In addition, the repopulated SHs showed storage of glycogen (Fig. 6B) .
Although ADMSCs seemed to be engrafted in the recipient's liver, no massive proliferation was obtained (Fig. 6C, D) .
Discussion
HT has been studied as an alternative method to liver transplantation in both the laboratory and clinical setting. However, it has not been prevalent as a standard therapeutic option, mainly because of the limited number of hepatocytes at one time and the shortage of transplantable primary hepatocytes (4, 22) . To overcome these hurdles, the methods for growth of transplanted hepatocytes in the recipient, or the development or availability of substitute for primary hepatocytes, such as xenogeneic hepatocytes, fetal hepatocytes, and hepatic stem cells/progenitor cells have been explored.
The transplanted hepatocytes must grow over host hepatocytes to achieve repopulation in the host liver. Portal vein embolization (PVE) is often used in the patient with a scheduled extended hepatectomy, as a preoperative intervention to elicit liver hypertrophy in the nonembolized lobes (16) . PVE is not accompanied by a lack of major tissue loss and we expected that this intervention would be a less invasive substitution for a partial hepatectomy to induce cell repopulation.
In this study, we ligated a branch of the portal vein, supplying only one lobe, instead of PVE, because the animals were too small to carry out embolization.
We performed partial HIR for 30% of the whole liver in order to induce minimal hepatic injury due to irradiation. As a result, a massive repopulation was obtained only in the irradiated nonligated lobe, but the therapeutic effect was significant, as shown by a reduction in the serum bilirubin levels. The serum bilirubin has been reported to decrease due to auxiliary partial liver transplantation with 12% of the liver in Gunn rat (23) , thus suggesting that HIR in even smaller regions of the liver could be sufficient in our model. Preparative PVBL alone, as a control, led to just a transient reduction in bilirubin. There have been some reports in which therapeutic effect by HT with preparative HIR Miyazaki, Yamanouchi, et al.
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alone was transient and minimum (8, 9) . PVBL could provide a selective growth stimulus to transplanted hepatocytes in combination with HIR, resulted in massive proliferation, and significant and continuous therapeutic effects.
Furthermore, the hepatocytes proliferated while retaining normal structure and function, as demonstrated by positive staining of connexin32, PCK-1, and glycogen.
PCNA staining showed that PVBL induced a regenerative stimulus to hepatocytes. We measured the levels of serum HGF, which is known as a strong stimulator for hepatocytes growth. Although supplying HGF via an adenovirus vector was demonstrated to induce proliferation of transplanted hepatocytes (10, 11, 14) , PVBL did not increase the levels of HGF, as observed in the clinical PVE study (16) . Liver regeneration is regulated by an orchestrated and complex response, involving not only HGF, but also various kinds of mediators. Further studies are needed to clarify the mechanism of proliferation.
Because of a shortage of transplantable primary hepatocytes, we analyzed the ability in engraftment and proliferation of substitutive cells with the partial HIR+PVBL model. SHs are known as progenitor cells in normal liver.
As we expected, SHs proliferated in shorter periods than PHs did, due to the hepatic function of glycogen storage. Although, in the present study, we did not assess either the characteristics of repopulated SHs or the therapeutic effects of (24) . SHs are in the non-parenchymal fraction in the liver (17, 18, 24) . In most clinical cases, hepatocytes for transplantation must be isolated from cadaver livers that were judged unsuitable for liver transplantation, i.e., macrosteatosis due to nonviral cirrhosis. These 
